Changzhou Qianhong Bio-Pharma Co. Ltd. A | Ownership
Companies that own Changzhou Qianhong Bio-Pharma Co. Ltd. A
The Vanguard Group, Inc.
1,700,250
0.2%
0
0%
07/31/2018
E Fund Management Co., Ltd.
1,243,090
0.15%
-969,800
0.01%
12/31/2017
GF Fund Management Co., Ltd.
543,054
0.06%
-176,532
0.01%
12/31/2017
FIAM LLC
377,600
0.04%
0
0%
07/31/2018
Changsheng Fund Management Co., Ltd.
36,400
0%
0
0%
12/31/2017
China Southern Asset Management Co., Ltd.
20,400
0%
-2,100
0%
12/31/2017
Hwabao WP Fund Management Co., Ltd.
14,200
0%
-2,500
0%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
2,132
0%
-500
0%
12/31/2017
CICC Fund Management Ltd.
200
0%
200
0%
12/31/2017
China Universal Asset Management Co., Ltd.
0
0%
-1,407,400
0%
12/31/2017
| Address |
No. 518 Yunhe Road
Changzhou Jiangsu 213125
China
|
|
Employees
|
- |
| Website |
http://www.qhsh.com.cn |
| Updated |
07/08/2019 |
| Changzhou Qianhong Biopharma Co., Ltd. engages in the research and development, production, and sale of bio-pharmaceutical products. It focuses on polysaccharides and enzymes. Its business scope covers lyophilized powder for injections, small volume parenteral solutions, tablets, hard capsules, granules, and active pharmaceutical ingredient (API) products. |
